Last --
Change Today 0.00 / 0.00%
Volume 0.0
601607 On Other Exchanges
Symbol
Exchange
601607 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

shanghai pharmaceuticals-a (601607) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SHANGHAI PHARMACEUTICALS-A (601607)

Related News

No related news articles were found.

shanghai pharmaceuticals-a (601607) Related Businessweek News

No Related Businessweek News Found

shanghai pharmaceuticals-a (601607) Details

Shanghai Pharmaceuticals Holding Co., Ltd., together with its subsidiaries, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People’s Republic of China. It operates through Production, Distribution, Retail, and Others segments. The company offers a range of products, including chemical and bio-pharms, modern Chinese medicine, healthcare products, medical devices etc. in various therapeutic areas, such as cardiovascular, systemic anti-infections, digestive system and immune-metabolism, neuropsychiatric, and antineoplastic, as well as anti-tumor and immunomodulatory, musculo-skeletal, respiratory, genito-urinary and sex hormone, blood and blood-forming organ, neurological, and other therapeutic areas. It provides its products in various dosage forms that include tablets, capsules, powder, mini-volume injections, eye-drops, inhalants, coagulants etc. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it operates a network of retail pharmacy stores, as well as engages in consulting service, assets management, investment holding operations etc. Further, the company manufactures and trades medicines and medical equipment; and rents properties, as well as wholesales chemicals and active pharmaceutical ingredients. As of December 31, 2015, it had 1,769 chain retail pharmacies under its brand family, including 1,167 directly operated pharmacies. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.

41,173 Employees
Last Reported Date: 03/18/16
Founded in 1994

shanghai pharmaceuticals-a (601607) Top Compensated Officers

President and Executive Director
Total Annual Compensation: CNY2.0M
Executive Director
Total Annual Compensation: --
Vice President
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

shanghai pharmaceuticals-a (601607) Key Developments

Shanghai Pharmaceuticals Holding Co., Ltd. Proposes Cash Dividend for the Year of 2015

Shanghai Pharmaceuticals Holding Co., Ltd. proposed cash dividend per 10 shares (tax included) of CNY 3.30000000 for the year of 2015.

Shanghai Pharmaceuticals Holding Co., Ltd., Board Meeting, May 06, 2016

Shanghai Pharmaceuticals Holding Co., Ltd., Board Meeting, May 06, 2016. Agenda: To discuss and approve issues including the proposal of electing executive director and non-executive director of sixth directorate, the proposal of electing independent non-executive director of sixth directorate and the proposal of recommending chair of fifth directorate.

Shanghai Pharmaceuticals Holding Co., Ltd. Proposes Amendments to the Articles of Association

The board of Shanghai Pharmaceuticals Holding Co., Ltd. proposed the following amendments to the articles of association. Article 145. The Board comprises 9 directors in which, among others, there shall be five (5) external directors (i.e. those not holding any position in the Company) and 4 independent directors (i.e. those independent of the shareholders of the Company and not holding any position in the Company). External directors shall account for at least one-half (1/2) of the Board, and independent directors shall account for at least one-third (1/3) of the Board; and at least one independent director shall be of accounting professional (i.e. those holding senior professional title or CPA qualification). Upon unanimous agreement by all the directors, the Board shall have an executive committee, comprising 3 or 4 executive directors, to perform its duties in accordance with this AOA. Article 4 of the Annex Rules of Procedure of the Board of Directors: Upon unanimous agreement by all the directors, the Board shall have an executive committee, comprising 3 or 4 executive directors; the members of the executive committee shall comprise all the executive directors of the Board at the time. Article 5 of the Annex Rules of Procedure of the Board of Directors: The term of office of the executive committee shall be the same as that of the Board. Upon the expiry of its term, any member of the executive committee may serve another term if re-elected. If any member of the executive committee is no longer the director of the Company during his or her term of office, he or she shall be automatically disqualified for the member of the executive committee. The proposed amendments to the Articles of Association are subject to the approval by the shareholders of the Company (the "Shareholders") at the 2015 annual general meeting of the Company. Prior to the shareholders' approval, the existing Articles of Association will continue to be in force.

 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
601607:CH CNY17.92 CNY +0.02

601607 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY63.85 CNY +2.50
Jointown Pharmaceutical Group Co Ltd CNY17.16 CNY +0.06
Nanjing Pharmaceutical Co Ltd CNY8.15 CNY -0.13
Wanjia Group Holdings Ltd $0.48 HKD 0.00
View Industry Companies
 

Industry Analysis

601607

Industry Average

Valuation 601607 Industry Range
Price/Earnings 15.6x
Price/Sales 0.4x
Price/Book 1.5x
Price/Cash Flow 11.2x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SHANGHAI PHARMACEUTICALS-A, please visit www.pharm-sh.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.